WESTFORD, Mass., May 31, 2013 /PRNewswire/ -- Cynosure, Inc.
(NASDAQ: CYNO), a leader in laser- and light-based treatments for
minimally invasive and non-invasive aesthetic applications, today
announced that its stock will be added to the S&P SmallCap 600®
Index as of the close of trading today.
"We are pleased to have been selected as a member of the
prestigious S&P SmallCap 600 Index, an achievement that is
consistent with our focus on delivering long-term value for
shareholders through industry leadership and consistent, profitable
growth," said Michael Davin,
Cynosure's president and chief executive officer. "Because a number
of funds track the S&P Dow Jones Indices, inclusion in the
S&P SmallCap 600 creates an additional opportunity to increase
our visibility and broaden our investor
base."
Introduced in 1994, the S&P SmallCap 600 is fast becoming
the preferred small cap index in the U.S., covering approximately
3% of the domestic equities market. The index is designed to be an
efficient portfolio of companies that meet specific inclusion
criteria to ensure that they are investable and financially viable.
Criteria include U.S. company status, market capitalization in the
range of $300 million to $1.4
billion, a public float of at least 50%, financial
viability, adequate liquidity and reasonable price and sector
representation. Complete details on the guidelines for maintaining
the index are available at www.standardandpoors.com.
About S&P Dow Jones Indices
S&P Dow Jones
Indices LLC, a subsidiary of The McGraw-Hill Companies, is the
world's largest, global resource for index-based concepts, data and
research. Home to iconic financial market indicators, such as the
S&P 500® and the Dow Jones Industrial
AverageSM, S&P Dow Jones Indices LLC has over 115
years of experience constructing innovative and transparent
solutions that fulfill the needs of institutional and retail
investors. More assets are invested in products based upon our
indices than any other provider in the world. With over 830,000
indices covering a wide range of assets classes across the globe,
S&P Dow Jones Indices LLC defines the way investors measure and
trade the markets. To learn more about our company, please visit
www.spdji.com.
About Cynosure, Inc.
Cynosure develops and
markets aesthetic treatment systems that are used by physicians and
other practitioners to perform non-invasive and minimally invasive
procedures to remove hair, treat vascular and pigmented lesions,
remove multi-colored tattoos, rejuvenate the skin, liquefy and
remove unwanted fat through laser lipolysis, reduce cellulite and
treat onychomycosis. Cynosure's products include a broad range of
laser and other light-based energy sources, including Alexandrite,
pulse dye, Q-switched, Nd:YAG and diode lasers, as well as intense
pulsed light. Cynosure was founded in 1991. For corporate or
product information, visit Cynosure's website at
www.cynosure.com.
Forward-Looking Statements
Any statements in
this press release about future expectations, plans and prospects
for Cynosure, Inc., as well as other statements containing the
words "believes," "anticipates," "plans," "expects," "will" and
similar expressions, constitute forward-looking statements within
the meaning of The Private Securities Litigation Reform Act of
1995. Actual results may differ materially from those indicated by
such forward-looking statements as a result of various important
factors, including levels of demand for procedures performed with
Cynosure products and for Cynosure products themselves, Cynosure's
ability to maintain its profitability, competition in the aesthetic
laser industry, general business and economic conditions, effects
of acquisitions that Cynosure has made or may make, Cynosure's
ability to develop and commercialize new products, Cynosure's
reliance on sole source suppliers, the inability to accurately
predict the timing or outcome of regulatory decisions, and
economic, market, technological and other factors discussed in
Cynosure's most recent Annual Report on Form 10-K, which is filed
with the Securities and Exchange Commission. In addition, the
forward-looking statements included in this press release represent
Cynosure's views as of the date of this press release. Cynosure
anticipates that subsequent events and developments will cause its
views to change. However, although Cynosure may elect to update
these forward-looking statements at some point in the future, it
specifically disclaims any obligation to do so. These
forward-looking statements should not be relied upon as
representing Cynosure's views as of any date subsequent to the date
of this press release.
Contacts:
|
|
|
|
|
|
Timothy
Baker
|
|
Scott
Solomon
|
Executive VP,
Treasurer and CFO
|
|
Vice
President
|
Cynosure,
Inc.
|
|
Sharon
Merrill
|
978.256.4200
|
|
617.542.5300
|
TBaker@cynosure.com
|
|
CYNO@investorrelations.com
|
SOURCE Cynosure, Inc.